Replies to post #317223 on Bioelectronics Corp (BIEL)

[GetSeriousOK]

The point is: IF Ilfeld conducts a full-scale clinical trial of the ActiPatch after his Pilot Studies, he won't finish before BIEL's patents expire.

So all the hype about Ilfeld is unfounded.

Still LYAO?

I 'm not laughing. I'm shaking my head though.